分享至
证券时报e公司讯，华仁药业(300110)4月20日晚间公告，子公司取得左氧氟沙星注射液药品注册证书。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
